The cover photo shows aerodynamic particle size distribution (APSD) testing, using an NGI, critical in the development and routine analysis of nebulized drug therapies. Photo courtesy of Intertek Melbourn, Saxon Way, Melbourn, Hertfordshire, SG8 6DN, United Kingdom, Tel.: +44 1763 261648, bd.melbourn@intertek.com, www.intertek.com
V o l u m e 1 7 N u m b e r 2 A p r i l 2 0 2 3
Inhalation
CLICK HERE
TO RENEW TODAY!
Spray drying to enable new inhaled
drug products
Exploring robustness of the pharmacopeial
methods for testing DPIs; Part I: DDU
Cross-industry organizations: An update
from PQRI
Back page: Research focus on nasal
biopharmaceutics: A workshop
